Taurine لـ Nighttime Pain-Related Sleep Disruption
B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003Dtaurine\u0026condition\u003Dnighttime\u002Dpain\u002Dsleep';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
الخلاصة
Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
Key Study Findings
Controlled Clinical Trial
n=32
12 weeks
Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None
مقابل: Standard care alone
Outcome: Itch and insomnia improvement in atopic dermatitis
التأثير: None
0.0449 (itch), 0.0089 (insomni
المجتمع المدروس: Patients with atopic dermatitis and mild-moderate negative emotions
Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None
مقابل: None
Outcome: None
التأثير: None
p < .05
المجتمع المدروس: Insomnia patients
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None
مقابل: None
Outcome: Pain outcomes
التأثير: None
None
المجتمع المدروس: Insomnia patients
Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None
مقابل: None
Outcome: Energy drink consumption and adverse effects
التأثير: None
None
المجتمع المدروس: Adolescents
Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None
مقابل: None
Outcome: rat model of cardiorenal insomnia from in vitro …
التأثير: None
None
المجتمع المدروس: None
Review
Assessment and treatment of insomnia in adult patients with alcohol use disorders.
Dose: None
مقابل: None
Outcome: None
التأثير: None
None
المجتمع المدروس: insomnia patients
Key Statistics
9
الدراسات
32
المشاركون
↔
Mixed
B
التقييم
Referenced Papers
Asian Pacific journal …
2025
6 اقتباسات
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Other
PloS one
2024
5 اقتباسات
Frontiers in medicine
2024
4 اقتباسات
Revista espanola de …
2022
2 اقتباسات
Zhongguo Zhong yao …
2020
5 اقتباسات
Alcohol (Fayetteville, N.Y.)
2015
122 اقتباسات
British journal of …
2014
111 اقتباسات
Alcohol and alcoholism …
2011
40 اقتباسات
Journal of the …
2008
300 اقتباسات
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
الجرعات الشائعة
- sleep:
- 500-2,000 mg, 1 hour before bed
الحد الأعلى: 3,000 mg/day considered safe in clinical studies
الجرعات المدروسة في الأبحاث
| الجرعة | المدة | التأثير | ن |
|---|---|---|---|
| None | 12 weeks | Positive | 32 |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
أفضل وقت للتناول: 1 hour before bed
Safety & Side Effects
الآثار الجانبية المُبلّغ عنها
- ⚠ Generally well tolerated
- ⚠ Mild GI discomfort at high doses
- ⚠ Drowsiness (desired for sleep use)
التفاعلات المعروفة
- ● Lithium — taurine may alter lithium excretion
- ● Antihypertensives — may have additive blood pressure lowering effects
- ● CNS depressants — potential additive sedative effects
الحد الأقصى المسموح به: 3,000 mg/day considered safe in clinical studies
استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
Frequently Asked Questions
Does Taurine help with Nighttime Pain-Related Sleep Disruption?
Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Nighttime Pain-Related Sleep Disruption management. Our evidence grade is B (Good Evidence).
How much Taurine should I take for Nighttime Pain-Related Sleep Disruption?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and Nighttime Pain-Related Sleep Disruption?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.
Related Evidence
Taurine لحالات أخرى
References
- [1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
- [2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
- [3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
- [4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
- [5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
- [6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
- [7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
- [8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
- [9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed
إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.